Demonstrates improved financial risk classification in Chinese manufacturing companies, indicating practical advantages.
Timely identification of company financial risks is crucial for investors and regulators. However, existing studies overlook the class imbalance caused by the scarcity of high-risk samples, and the interpretability of deep models is insufficient, making it difficult to meet the practical needs. To address these problems, we propose a classification model named FA-LSTFormer, which models a company’s financial risk as low-, medium- and high-warning tasks. FA-LSTFormer employs LSTM and Transformer to decouple the short-term continuity and long-term dependency inherent in financial data. To further attend to indicator-level nuances, we incorporate a Risk-Sensitive Hierarchical Indicator Attention (RSHA) module. Moreover, given the pronounced class imbalance where high-risk events are substantially underrepresented, we further propose a Class-Imbalance-Aware Focal Loss (CIFL) function to prioritize these minor yet critical samples and suppress false negatives. On the dataset of Chinese A-share manufacturing listed companies, experimental results show that our FA-LSTFormer achieves superior performance in accuracy, precision, recall, F1-score and AUC, achieving 92.76%, 93.13%, 91.84%, 92.48%, and 95.27%, respectively. Compared to the suboptimal LTR-Net, it improves these metrics by 1.64–3.60%. Compared to the LSTM–Transformer baseline, FA-LSTFormer improves on it by 4.30–9.13%. In the risk-oriented decision evaluation, FA-LSTFormer achieves a warning ROC of 0.954 for the high-risk class and lowers the error rate to 9.82%. It maintains an accuracy rate of 84.46% even after three years of early warning and exhibits strong robustness across different warning thresholds and company sizes. These results verify the advantages of FA-LSTFormer in both algorithmic performance and practical early-warning applications.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: